DocGo Inc. (DCGO)
USD 4.29
(-2.39%)
USD 4.29
(-2.39%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 32.72 Million USD | -6.75% |
| 2022 | 32.39 Million USD | 94.82% |
| 2021 | 28.06 Million USD | 283.3% |
| 2020 | -9.25 Million USD | 42.62% |
| 2019 | -16.58 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 14.35 Million USD | -28.45% |
| 2024 Q1 | 20.05 Million USD | 23.14% |
| 2023 FY | - USD | -6.75% |
| 2023 Q2 | 5.5 Million USD | 272.14% |
| 2023 Q4 | 16.7 Million USD | 29.52% |
| 2023 Q1 | -3.19 Million USD | -150.07% |
| 2023 Q3 | 12.89 Million USD | 134.2% |
| 2022 Q2 | 6.46 Million USD | -47.65% |
| 2022 Q1 | 12.35 Million USD | 0.41% |
| 2022 FY | - USD | 94.82% |
| 2022 Q4 | 6.38 Million USD | -29.05% |
| 2022 Q3 | 9 Million USD | 39.2% |
| 2021 Q1 | -276.28 Thousand USD | 91.72% |
| 2021 Q4 | 12.3 Million USD | 262.28% |
| 2021 Q3 | 3.39 Million USD | 55.53% |
| 2021 Q2 | 2.18 Million USD | 890.33% |
| 2021 FY | - USD | 283.3% |
| 2020 Q2 | -390.21 Thousand USD | 91.68% |
| 2020 Q1 | -4.68 Million USD | 0.0% |
| 2020 Q4 | -3.33 Million USD | -184.91% |
| 2020 FY | - USD | 42.62% |
| 2020 Q3 | -1.17 Million USD | -200.02% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 82.696% |
| Addus HomeCare Corporation | 106.55 Million USD | 69.289% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | -15.588% |
| Amedisys, Inc. | 216.91 Million USD | 84.913% |
| American Oncology Network, Inc. | -39.35 Million USD | 183.162% |
| Astrana Health, Inc. | 123.68 Million USD | 73.542% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 26.208% |
| IMAC Holdings, Inc. | -5.94 Million USD | 650.3% |
| biote Corp. | 9.23 Million USD | -254.399% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 414.143% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 74.697% |
| COMPASS Pathways plc | -123.8 Million USD | 126.433% |
| The Ensign Group, Inc. | 353.23 Million USD | 90.736% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 56.489% |
| InnovAge Holding Corp. | 1.15 Million USD | -2735.805% |
| Assure Holdings Corp. | -19.82 Million USD | 265.079% |
| The Joint Corp. | 9.14 Million USD | -257.976% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 131.189% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 310.388% |
| ModivCare Inc. | -26.75 Million USD | 222.337% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -8415.42% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | 659.5% |
| Option Care Health, Inc. | 376.79 Million USD | 91.315% |
| P3 Health Partners Inc. | -81.07 Million USD | 140.366% |
| P3 Health Partners Inc. | -81.07 Million USD | 140.366% |
| The Pennant Group, Inc. | 30.36 Million USD | -7.759% |
| Surgery Partners, Inc. | 446.1 Million USD | 92.664% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 1253.967% |
| Talkspace, Inc. | -22.01 Million USD | 248.663% |
| Talkspace, Inc. | -22.01 Million USD | 248.663% |
| The Oncology Institute, Inc. | -70.45 Million USD | 146.449% |
| The Oncology Institute, Inc. | -70.45 Million USD | 146.449% |